Interobserver variability of histopathological assessment in pT1 colorectal carcinoma


Por: de Gordoa, KS, Daca-Alvarez, M, Rodrigo-Calvo, M, Archilla, I, Lopez-Prades, S, Aguirre, JJ, Alarcon-Molero, L, Jurado, MC, Canosa, A, Giner, F, González-Lois, C, Jimeno, M, Jurado, I, Machado, I, Martínez-Ciarpaglini, C, Musulen, E, Naranjo, D, Papaleo, N, Peña, C, Rosiñol, O, Sánchez-Yuste, R, Benítez, GTV, Pellisé, M and Cuatrecasas, M

Publicada: 1 mar 2026 Ahead of Print: 1 dic 2025
Resumen:
Aims Pathological evaluation of colorectal carcinoma (CRC) diagnosed at stage pT1 is challenging. Nevertheless, it is crucial for treatment guiding and to determine the patient's prognosis. This study aimed to assess the interobserver variability in the histopathological evaluation of pT1 CRC.Methods and results A retrospective multicentre pT1 CRC cohort study was designed (EpiT1 consortium). A task force comprising 20 experienced pathologists conducted the histopathological evaluation using digitalized haematoxylin-eosin (H&E) slides. A pilot study was performed with 10 cases, and afterwards, a consensus meeting was held to assess interobserver variability. Then, a concordance study was performed by assessing 70 new pT1 CRC cases. We used percentage agreement and Gwet's Agreement Coefficient 1 for categorical variables, and intraclass correlation coefficient (ICC) for continuous variables. In the pilot study, histological grade and perineural invasion (PNI) demonstrated 100% agreement, with good concordance for lymphovascular invasion (LVI), tumour budding (TB), poorly differentiated clusters (PDC) and margin assessment. The concordance study showed high agreement (>= 90%) on histological grade, PDC, PNI and LVI. Submucosal invasion depth showed excellent reliability in the concordance study (ICC = 0.97). Notably, in both studies, the agreement of PDC was higher than for TB. Lower concordance was observed on stromal lymphocytes and the status of muscularis mucosae.Conclusions Our results emphasize the need for standardization in evaluating pT1 CRC to improve the concordance among pathologists, and the precision of digital measurements. Moreover, the addition of PDC assessment in pT1 CRC diagnostic guidelines could help to improve the accuracy of risk stratification and reliably predict prognosis.

Filiaciones:
de Gordoa, KS:
 Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Barcelona, Spain

Daca-Alvarez, M:
 Hosp Clin Barcelona, Gastroenterol Dept, Barcelona, Spain

Archilla, I:
 Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Barcelona, Spain

Lopez-Prades, S:
 Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Barcelona, Spain

Aguirre, JJ:
 Hosp Univ Araba, Pathol Dept, Vitoria, Spain

 Bioaraba HRI, Vitoria, Spain

Alarcon-Molero, L:
 Hosp Gen Valdepenas, Pathol Dept, Ciudad Real, Spain

Jurado, MC:
 Hosp Univ 12 Octubre, Pathol Dept, Madrid, Spain

Canosa, A:
 Hosp Univ La Ribera, Pathol Dept, Alzira, Spain

Giner, F:
 Hosp Univ & Politecn La Fe, Pathol Dept, Valencia, Spain

 Univ Valencia, Valencia, Spain

González-Lois, C:
 Hosp Univ Puerta Hierro, Pathol Dept, Majadahonda, Spain

:
 Hosp Badalona Germans Trias & Pujol, Pathol Dept, Badalona, Spain

 Inst Germans Trias & Pujol, Badalona, Spain

Jurado, I:
 Hosp Univ Consorsi Sanitari Terrassa, Pathol Dept, Terrassa, Spain

Machado, I:
 Inst Valenciano Oncol, Pathol Dept, Valencia, Spain

 Hosp QuironSalud, Pathol Lab, Valencia, Spain

Martínez-Ciarpaglini, C:
 Univ Valencia, Valencia, Spain

 Hosp Clin Univ Valencia, Pathol Dept, Valencia, Spain

 Biomed Res Inst INCLIVA, Valencia, Spain

:
 Hosp Univ Gen Catalunya, Pathol Dept, Grp QuironSalud, Sant Cugat Del Valles, Spain

 Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Badalona, Spain

Naranjo, D:
 Hosp Mar, Pathol Dept, Barcelona, Spain

Papaleo, N:
 Corporacio Sanitaria Parc Tauli, Pathol Dept, Sabadell, Spain

Peña, C:
 Complejo Hosp Univ, Pathol Dept, Albacete, Spain

Rosiñol, O:
 Althaia Xarxa Assistencial Univ, Pathol Dept, Manresa, Spain

Sánchez-Yuste, R:
 Hosp Univ Puerta Hierro, Pathol Dept, Majadahonda, Spain

Benítez, GTV:
 Hosp Univ Puerta Hierro, Pathol Dept, Majadahonda, Spain

Pellisé, M:
 Univ Barcelona, Dept Med, Barcelona, Spain

 Hosp Clin Barcelona, Gastroenterol Dept, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain

Cuatrecasas, M:
 Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain

 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
ISSN: 13652559





Histopathology
Editorial
Blackwell Publishing Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 88 Número: 4
Páginas: 868-880
WOS Id: 001638393100001
ID de PubMed: 41392996
imagen Green Submitted, hybrid

MÉTRICAS